Mentions of cloud increased by a CAGR of 16% in the pharmaceutical industry since 2020 

The global pharmaceutical industry experienced a 16% rise in compound annual growth rate (CAGR) in company filings mentions of cloud since 2020. Key companies in terms of mentions include Kintara Therapeutics, Evelo Biosciences and Pulmatrix, according to GlobalData’s analysis of over 1,400 pharmaceutical company filings.  

 Notably, since 2020, cloud was among the five most referenced technology themes in terms of mentions, after cybersecurity, big data and artificial intelligence, according to GlobalData's Company Filings database. Mentions related to cloud decreased by 11% year-on-year in 2021 but increased by 52% year-on-year in 2022.  

Of the 50 leading companies in the pharmaceutical industry, Sanofi had the highest year-on-year increase in references to cloud in 2022. GlobalData identified 28 cloud-related sentences in the company's filings in 2022, 2% of all sentences. Meanwhile, UCB had the highest year-on-year increase in references for cloud in 2021. GlobalData identified six cloud related sentences in the company's filings in 2021, 0.6% of all sentences.  

GlobalData’s Company Filings Analytics also applies a sentiment weight to reference sentences, based on how positive the sentiment has turned. Sentiment score is based on the level of positivity on a scale of 0 to 1. The average sentiment score for cloud in 2022 was 0.62, which was more positive compared to the average industry sentiment of 0.59.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.  

Global Data’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.